Form D · Pharmaceuticals
ND Acquisitions Corp.
Nashville, TN · CIK 0001464225
Offering snapshot reported Mar 18, 2015 · SEC filing
- Reported sold
- $3.85M Offering amount: $3.85M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2015 | Initial | $3,849,424 | No comparison | 7 | SEC filing |
| Jul 2, 2014 | Amendment | $11,031,858 | $2,499,999vs Jun 28, 2013 | 12 | SEC filing |
| Jun 28, 2013 | Initial | $8,531,859 | No comparison | 12 | SEC filing |
| Jan 24, 2013 | Initial | $1,947,385 | No comparison | 10 | SEC filing |
| Jul 19, 2012 | Initial | $2,000,000 | No comparison | 11 | SEC filing |
| Sep 22, 2011 | Initial | $12,224,529 | No comparison | 13 | SEC filing |
| Mar 10, 2011 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| Oct 5, 2010 | Initial | $1,501,115 | No comparison | 7 | SEC filing |
| May 21, 2009 | Initial | $5,473,606 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-236174
Source: Form D, filed Mar 18, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jim Beaumariage | Executive |
| Jim Beaumarriage | Executive |
| Dennis C. Bottorff | Director |
| C. Daniel Haron | Director, Executive |
| Mary Howard | Executive |
| David Kaufman | Director |
| Joseph Keane | Executive |
| Matthew A. King | Director |
| Kenneth M. Krakaur | Director |
| Linwood A. Lacy | Director |
| Linwood A. Lacy, Jr. | Director |
| Chris Maness | Executive |
| James Reed Mc Knight, Jr. | Executive |
| Edgardo A. Mercadante | Director, Executive |
| Donald Taylor | Director, Executive |
| James Usdan | Director, Executive |
| Ken Woody | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5215 Linbar Drive, Suite 210
Nashville, TN, 37211
Nashville, TN, 37211